Alaunos Therapeutics | ZIOP - Pre Tax Profit


Alaunos Therapeutics reported $-7.84M in Pre-Tax Profit for its fiscal quarter ending in December of 2023.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Amgen USD 2.08B 570M Mar/2026
AstraZeneca USD 4.81B 894M Jun/2026
Baxter International USD 362M 368M Jun/2026
Biogen USD 647.3M 269.6M Jun/2026
Bioline Rx USD -2.59M 352K Mar/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Celltrion KRW 11.84B 1.34B Mar/2026
Corcept Therapeutics USD -44.72M 54.62M Mar/2026
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Curis USD -24.2M 43.56M Mar/2026
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 11.8B 2.17B Jun/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Incyte USD 751.51M 407.91M Jun/2026
Intrexon USD -60.48M 27.09M Jun/2024
Ionis Pharmaceuticals USD -114M 21M Jun/2026
J&J USD 8.66B 839M Jun/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Karyopharm Therapeutics USD -22.39M 17.51M Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Merck USD -3.53B 6.95B Mar/2026
Neuren Pharmaceuticals AUD 19.21M 9.35M Dec/2025
Novartis USD 4.27B 430M Jun/2026
Organigram Holdings CAD -921K 40.8M Mar/2026
Pfizer USD -653M 5.84B Jun/2026
Pharma Mar EUR -993K 2.59M Jun/2026
PTC Therapeutics USD -2.46M 136.62M Mar/2026
Qiagen NV USD 85.83M 23.34M Mar/2026
Regeneron Pharmaceuticals USD 1.53B 696.6M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sartorius EUR 127M 30.8M Jun/2026
TG Therapeutics USD 10.23M 10.13M Jun/2026
Tilray USD -39.96M 39.19M Sep/2025
Verastem USD -36.59M 3.68M Mar/2026
Zealand Pharma A/S -394M 12.5M Mar/2026
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026